Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Miles

Showing results (331-340 of 370) with videos related to

Pageof 37
Sort By:
Plant Disease|April 20, 2023
A Rapid Glove-Based Inoculum Sampling Technique to Monitor <i>Erysiphe necator</i> in Commercial VineyardsSarah R Lowder, Tara M Neill, Amy B Peetz, et al.
Frontiers in Plant Science|August 21, 2024
Managing fruit rot diseases of <i>Vaccinium corymbosum</i>Kerri A Neugebauer, Chakradhar Mattupalli, Mengjun Hu, et al.
British Journal of Cancer|February 25, 2010
Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases--the UK experienceS Sutherland, S Ashley, D Miles, et al.
Journal of Pharmacy Practice|December 28, 2017
Prevention Strategies Against HIV Transmission: A Proactive ApproachAntonio J Carrion, Jovan D Miles, Juan F Mosley, et al.
Journal of the American Chemical Society|December 12, 2018
Total Enzyme Syntheses of Napyradiomycins A1 and B1Shaun M K McKinnie, Zachary D Miles, Peter A Jordan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Randomized, open-label, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancerJ A Oshaughnessy, J Blum, V Moiseyenko, et al.
Cancer|December 20, 2002
Doxorubicin-paclitaxel: a safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European Organization for Research and Treatment of Cancer multicenter trialLaura Biganzoli, Tanja Cufer, Peter Bruning, et al.
Plos One|October 15, 2015
A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic HistopathologyR Brian Stevens, Kirk W Foster, Clifford D Miles, et al.
Plant Disease|May 5, 2025
Development of a translation elongation factor 1-alpha (TEF) based TaqMan qPCR assay for <i>Diaporthe humulicola</i>, the causal agent of halo blight of hopRoss Joaquin Hatlen, Shay Szymanski, Nanci Adair, et al.
Emerging Infectious Diseases|November 21, 1997
Quantitative microbiology: a basis for food safetyT A McMeekin, J Brown, K Krist, et al.
Pageof 37

Showing results (331-340 of 370) with videos related to

Sort By:
Pageof 37
Plant Disease|April 20, 2023
A Rapid Glove-Based Inoculum Sampling Technique to Monitor <i>Erysiphe necator</i> in Commercial VineyardsSarah R Lowder, Tara M Neill, Amy B Peetz, et al.
Frontiers in Plant Science|August 21, 2024
Managing fruit rot diseases of <i>Vaccinium corymbosum</i>Kerri A Neugebauer, Chakradhar Mattupalli, Mengjun Hu, et al.
British Journal of Cancer|February 25, 2010
Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases--the UK experienceS Sutherland, S Ashley, D Miles, et al.
Journal of Pharmacy Practice|December 28, 2017
Prevention Strategies Against HIV Transmission: A Proactive ApproachAntonio J Carrion, Jovan D Miles, Juan F Mosley, et al.
Journal of the American Chemical Society|December 12, 2018
Total Enzyme Syntheses of Napyradiomycins A1 and B1Shaun M K McKinnie, Zachary D Miles, Peter A Jordan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Randomized, open-label, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancerJ A Oshaughnessy, J Blum, V Moiseyenko, et al.
Cancer|December 20, 2002
Doxorubicin-paclitaxel: a safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European Organization for Research and Treatment of Cancer multicenter trialLaura Biganzoli, Tanja Cufer, Peter Bruning, et al.
Plos One|October 15, 2015
A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic HistopathologyR Brian Stevens, Kirk W Foster, Clifford D Miles, et al.
Plant Disease|May 5, 2025
Development of a translation elongation factor 1-alpha (TEF) based TaqMan qPCR assay for <i>Diaporthe humulicola</i>, the causal agent of halo blight of hopRoss Joaquin Hatlen, Shay Szymanski, Nanci Adair, et al.
Emerging Infectious Diseases|November 21, 1997
Quantitative microbiology: a basis for food safetyT A McMeekin, J Brown, K Krist, et al.
Pageof 37